Scale-up insulin access urgently, drugmakers told

For SciDevNet, Syriacus Buguzi writes about the Access to Medicine Foundation's report on what pharmaceutical companies are doing to address access to insulin for people living in low- and middle-income countries.

He spoke to Claudia Martinez, our Research Programme Manager for diabetes:

“What we want to see as the first step from these companies is to walk away from scattered initiatives and work towards models that ensure more systematic access for patients.”